Ligand structures of synthetic deoxa-pyranosylamines with raucaffricine and strictosidine glucosidases provide structural insights into their binding and inhibitory behaviours

J Enzyme Inhib Med Chem. 2015 Jun;30(3):472-8. doi: 10.3109/14756366.2014.949252. Epub 2014 Aug 20.

Abstract

Insight into the structure and inhibition mechanism of O-β-d-glucosidases by deoxa-pyranosylamine type inhibitors is provided by X-ray analysis of complexes between raucaffricine and strictosidine glucosidases and N-(cyclohexylmethyl)-, N-(cyclohexyl)- and N-(bromobenzyl)-β-d-gluco-1,5-deoxa-pyranosylamine. All inhibitors anchored exclusively in the catalytic active site by competition with appropriate enzyme substrates. Thus facilitated prospective elucidation of the binding networks with residues located at <3.9 Å distance will enable the development of potent inhibitors suitable for the production of valuable alkaloid glucosides, raucaffricine and strictosidine, by means of synthesis in Rauvolfia serpentina cell suspension cultures.

Keywords: Crystallization; glucosidase inhibition; structure elucidation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Binding Sites / drug effects
  • Cyclopentanes / chemistry
  • Cyclopentanes / pharmacology*
  • Dose-Response Relationship, Drug
  • Glucosidases / antagonists & inhibitors*
  • Glucosidases / chemistry
  • Glucosidases / metabolism*
  • Ligands
  • Models, Molecular
  • Molecular Structure
  • Rauwolfia / cytology
  • Rauwolfia / enzymology
  • Structure-Activity Relationship
  • Sugar Alcohols / chemistry
  • Sugar Alcohols / pharmacology*

Substances

  • Cyclopentanes
  • Ligands
  • Sugar Alcohols
  • Glucosidases
  • raucaffricine beta-glucosidase
  • strictosidine glucosidase